14:10:33 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-12-05 Årsstämma 2025
2024-11-05 Bokslutskommuniké 2024
2024-08-20 Kvartalsrapport 2024-Q3
2024-05-07 Kvartalsrapport 2024-Q2
2024-02-09 Kvartalsrapport 2024-Q1
2023-12-08 Halvårsutdelning COLO B 16
2023-12-07 Årsstämma 2024
2023-11-09 Bokslutskommuniké 2023
2023-08-17 Kvartalsrapport 2023-Q3
2023-05-15 Halvårsutdelning COLO B 5
2023-05-11 Kvartalsrapport 2023-Q2
2023-02-03 Kvartalsrapport 2023-Q1
2022-12-02 Halvårsutdelning COLO B 15
2022-12-01 Årsstämma 2023
2022-11-07 Bokslutskommuniké 2022
2022-08-17 Kvartalsrapport 2022-Q3
2022-05-09 Halvårsutdelning COLO B 5
2022-05-05 Kvartalsrapport 2022-Q2
2022-01-25 Kvartalsrapport 2022-Q1
2021-12-03 Halvårsutdelning COLO B 14
2021-12-02 Årsstämma 2022
2021-11-01 Bokslutskommuniké 2021
2021-08-18 Kvartalsrapport 2021-Q3
2021-05-10 Halvårsutdelning COLO B 5
2021-05-06 Kvartalsrapport 2021-Q2
2021-02-06 Kvartalsrapport 2021-Q1
2020-12-04 Halvårsutdelning COLO B 13
2020-12-03 Årsstämma 2021
2020-11-03 Bokslutskommuniké 2020
2020-08-18 Kvartalsrapport 2020-Q3
2020-05-11 Halvårsutdelning COLO B 5
2020-05-06 Kvartalsrapport 2020-Q2
2020-02-06 Kvartalsrapport 2020-Q1
2019-12-06 Halvårsutdelning COLO B 12
2019-12-05 Årsstämma 2020
2019-11-05 Bokslutskommuniké 2019
2019-08-14 Kvartalsrapport 2019-Q3
2019-05-06 Halvårsutdelning COLO B 5
2019-05-02 Kvartalsrapport 2019-Q2
2019-02-05 Kvartalsrapport 2019-Q1
2018-12-06 Halvårsutdelning COLO B 11
2018-12-05 Årsstämma 2019
2018-11-01 Bokslutskommuniké 2018
2018-08-08 Kvartalsrapport 2018-Q3
2018-05-07 Halvårsutdelning COLO B 5
2018-05-03 Kvartalsrapport 2018-Q2
2018-02-01 Kvartalsrapport 2018-Q1
2017-12-08 Halvårsutdelning COLO B 10.5
2017-12-07 Årsstämma 2018
2017-11-02 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q3
2017-05-08 Halvårsutdelning COLO B 4.5
2017-05-03 Kvartalsrapport 2017-Q2
2017-02-01 Kvartalsrapport 2017-Q1
2016-12-06 Halvårsutdelning COLO B 9
2016-12-05 Årsstämma 2017
2016-11-02 Bokslutskommuniké 2016
2016-08-16 Kvartalsrapport 2016-Q3
2016-05-09 Halvårsutdelning COLO B 4.5
2016-05-03 Kvartalsrapport 2016-Q2
2016-02-02 Kvartalsrapport 2016-Q1
2015-12-10 Halvårsutdelning COLO B 8
2015-12-09 Årsstämma 2016
2015-11-03 Bokslutskommuniké 2015
2015-08-11 Kvartalsrapport 2015-Q3
2015-05-07 Halvårsutdelning COLO B 4.5
2015-05-05 Kvartalsrapport 2015-Q2
2015-01-29 Kvartalsrapport 2015-Q1
2014-12-05 Halvårsutdelning COLO B 7.5
2014-12-04 Årsstämma 2015
2014-10-30 Bokslutskommuniké 2014
2014-05-08 Halvårsutdelning COLO B 4
2013-12-06 Halvårsutdelning COLO B 7
2013-12-05 Årsstämma 2014
2013-10-31 Bokslutskommuniké 2013
2013-08-13 Kvartalsrapport 2013-Q3
2013-05-06 Halvårsutdelning COLO B 3
2013-04-30 Kvartalsrapport 2013-Q2
2013-01-30 Kvartalsrapport 2013-Q1
2012-12-19 Split COLO B 1:5
2012-12-11 Årsstämma 2013
2012-11-06 Bokslutskommuniké 2012
2012-08-15 Kvartalsrapport 2012-Q3
2012-04-26 Kvartalsrapport 2012-Q2
2012-01-25 Kvartalsrapport 2012-Q1
2011-12-08 Ordinarie utdelning COLO B 14.00 DKK
2011-12-07 Årsstämma 2012
2011-11-01 Bokslutskommuniké 2011
2011-08-17 Kvartalsrapport 2011-Q3
2011-06-21 Kapitalmarknadsdag 2011
2011-05-04 Kvartalsrapport 2011-Q2
2011-01-26 Kvartalsrapport 2011-Q1
2010-12-02 Ordinarie utdelning COLO B 10.00 DKK
2009-12-02 Ordinarie utdelning COLO B 7.00 DKK
2004-12-16 Split COLO B 1:2

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Coloplast är verksamma inom medicinteknik. Bolaget är en utvecklare av produkter och tjänster anpassade för människor med olika medicinska tillstånd. Bolagets produktportfölj består av vårdutrustning och används huvudsakligen inom områdena stomi, inkontinens, urologi, samt hud- och sårvård. Idag är bolaget verksamma på en global marknad via egna försäljningskanaler. Bolaget grundades 1954 och har sitt huvudkontor i Humlebæk.
2020-01-20 16:06:43

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2019. The policy is available on the Group website at this address:
https://www.coloplast.com/management-remuneration/

1Details of the person discharging managerial responsibilities/person closely associated
a)NameKristian Villumsen
2Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0054,102
d)Aggregated information 
-  Aggregated volume54,102 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue


1Details of the person discharging managerial responsibilities/person closely associated
a)NameAnders Lonning-Skovgaard
2Reason for the notification
a)Position/statusExecutive Vice President, CFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0027,473
d)Aggregated information 
-  Aggregated volume27,473 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue


1Details of the person discharging managerial responsibilities/person closely associated
a)NamePaul Marcun
2Reason for the notification
a)Position/statusExecutive Vice President, Chronic Care
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0030,407
d)Aggregated information 
-  Aggregated volume30,407 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue


1Details of the person discharging managerial responsibilities/person closely associated
a)NameAllan Rasmussen
2Reason for the notification
a)Position/statusExecutive Vice President, Global Operations
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0025,500
d)Aggregated information 
-  Aggregated volume25,500 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

  

1Details of the person discharging managerial responsibilities/person closely associated
a)NameLars Rasmussen
2Reason for the notification
a)Position/statusChairman of the Board of Directors
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0014,904
d)Aggregated information 
-  Aggregated volume14,904 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: +45 4911 3616.